Safety Study of Bone Marrow Cell Concentrate Prepared Using the Magellan System to Treat Critical Limb Ischemia (CLI)

Clinical trial NCT01386216 · COMPLETED

Trial details

NCT number: NCT01386216
Sponsor: Arteriocyte, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Critical Limb Ischemia (CLI)Peripheral Vascular Disease (PVD)

Start date: 2011-04-01
Primary completion: 2016-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.